Corindus’ CorPath GRX cleared for both PCI, peripheral vascular intervention

Daniel Allar | | Cardiovascular Business | Vascular & Endovascular

Already approved for robot-assisted PCI, Corindus Vascular Robotics’ CorPath GRX System is now cleared by the FDA for peripheral vascular interventions (PVIs). The system is the first to receive FDA clearance for both procedures.

According to Corindus, peripheral artery disease (PAD) affects an estimated 8.5 million people in the United States.

"My colleagues and I have seen first-hand how CorPath GRX can overcome the challenges of manual PCI and I am excited to apply the capabilities of robotics to effectively treat PAD patients," said Alan Lumsden, MD, chief of the department of cardiovascular surgery at Houston Methodist Hospital. "As a training site for future robotic interventionalists, I look forward to teaching these techniques to further enhance the quality of care for patients with both CAD and PAD."

Corindus is interested in exploring whether its technology can facilitate procedures performed by operators in remote locations, in addition to robot-assisted procedures. In January, the company announced it was partnering with Mayo Clinic to test the feasibility of “telestenting,” which could ultimately provide more access to PCI for rural and underserved populations.

""
Daniel Allar

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Related Content

New guidelines help interventional cardiologists manage chronic venous disease
Private equity firm jumps into vascular health with new investment
New report raises questions about data that helped heart drug gain FDA approval
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Angiographic catheters recalled due to safety risk
FDA clears blood clot removal system for treating pulmonary embolism

Around the web

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.